Gamco Investors, Inc. Et Al

recently disclosed that they own 13% of Exactech, Inc. (NASDAQ:EXAC) in a Schedule 13D/A disclosure that was filed with the Securities and Exchange Commission on Tuesday, November 21st. The investor owns 1,863,658 shares of the stock worth about $77,900,904. The reporting parties listed on the disclosure included Gabelli Funds, LLC ID No 134044523, GAMCO Investors, Inc ID No 134044521, Gabelli & Company Investment Advisers, Inc ID No 133379374, MJG Associates, Inc ID No 061304269, Teton Advisors, Inc ID No 134008049, GGCP, Inc ID No 133056041, GAMCO Investors, Inc ID No 134007862, Associated Capital Group, Inc ID No 473965991 and Mario J Gabelli. The disclosure is available through the SEC website at this hyperlink.

A number of other institutional investors also recently modified their holdings of EXAC. The Manufacturers Life Insurance Company increased its stake in shares of Exactech by 3.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 9,323 shares of the medical equipment provider’s stock worth $278,000 after purchasing an additional 289 shares in the last quarter. American International Group Inc. increased its stake in shares of Exactech by 7.1% during the 1st quarter. American International Group Inc. now owns 6,423 shares of the medical equipment provider’s stock worth $162,000 after purchasing an additional 424 shares in the last quarter. Teachers Advisors LLC increased its stake in shares of Exactech by 2.7% during the 2nd quarter. Teachers Advisors LLC now owns 21,549 shares of the medical equipment provider’s stock worth $642,000 after purchasing an additional 568 shares in the last quarter. Bessemer Group Inc. increased its stake in shares of Exactech by 5.4% during the 2nd quarter. Bessemer Group Inc. now owns 19,400 shares of the medical equipment provider’s stock worth $578,000 after purchasing an additional 1,000 shares in the last quarter. Finally, California Public Employees Retirement System increased its stake in shares of Exactech by 4.5% during the 2nd quarter. California Public Employees Retirement System now owns 23,100 shares of the medical equipment provider’s stock worth $688,000 after purchasing an additional 1,000 shares in the last quarter. 64.58% of the stock is owned by institutional investors.

WARNING: “Exactech, Inc. (EXAC) Stake Owned by Gamco Investors, Inc. Et Al” was posted by Watch List News and is the property of of Watch List News. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://www.watchlistnews.com/exactech-inc-exac-stake-owned-by-gamco-investors-inc-et-al-2/1718283.html.

A number of research analysts have recently weighed in on EXAC shares. Zacks Investment Research cut shares of Exactech from a “hold” rating to a “sell” rating in a research note on Wednesday, October 25th. BidaskClub cut shares of Exactech from a “hold” rating to a “sell” rating in a research note on Monday, July 31st. Gabelli cut shares of Exactech from a “buy” rating to a “hold” rating in a research note on Tuesday, October 24th. Robert W. Baird cut shares of Exactech from an “outperform” rating to a “neutral” rating and set a $42.00 price objective for the company. in a research note on Monday, October 23rd. Finally, Sidoti cut shares of Exactech from a “buy” rating to a “neutral” rating in a research note on Monday, October 23rd. One analyst has rated the stock with a sell rating and four have assigned a hold rating to the stock. Exactech currently has an average rating of “Hold” and an average price target of $42.00.

Exactech, Inc. (NASDAQ:EXAC) remained flat at $$41.80 during mid-day trading on Tuesday. The company had a trading volume of 138,000 shares, compared to its average volume of 63,653. The stock has a market capitalization of $600.51, a PE ratio of 34.54, a PEG ratio of 3.59 and a beta of 1.04. The company has a current ratio of 4.08, a quick ratio of 2.09 and a debt-to-equity ratio of 0.06. Exactech, Inc. has a 52-week low of $23.30 and a 52-week high of $42.75.

Exactech (NASDAQ:EXAC) last released its earnings results on Monday, October 30th. The medical equipment provider reported $0.20 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.23 by ($0.03). The firm had revenue of $61.40 million during the quarter, compared to analysts’ expectations of $61.78 million. Exactech had a return on equity of 7.22% and a net margin of 0.18%. analysts predict that Exactech, Inc. will post 1.29 EPS for the current year.

About Exactech

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Want to see what other hedge funds are holding EXAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exactech, Inc. (NASDAQ:EXAC).

Institutional Ownership by Quarter for Exactech (NASDAQ:EXAC)

Receive News & Ratings for Exactech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.